TrialJournal of child and adolescent psychopharmacology2020

Phase II/III Study of Lisdexamfetamine Dimesylate in Japanese Pediatric Patients with Attention-Deficit/Hyperactivity Disorder.

Hironobu Ichikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.